Esperion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.49716675
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, app...

3.15 0.00 (0.00%)

231.58% Gain from 52W Low

8.8M

XNAS Volume

XNAS 25 Jun, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.7 / 100

Technically Neutral

46.2 / 100

1Yr Price target upside is 1%

4 analysts

Esperion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, app...

231.58% Gain from 52W Low

SWOT Analysis

Esperion Therapeutics Inc Live Price Chart